Top Biotech Picks: “The Strong Will Survive And Thrive”
January 05, 2017 at 14:44 PM EST
After two volatile years, the biotech sector still faces rough times ahead with tough competition, push back from insurers and slowing volumes. But taking a line from Charles Darwin , analysts at Jefferies argue that ‘the strong will survive and thrive.” And just who are “the strong?” Jefferies’ top picks for 2017 include Celgene ( CELG ), Gilead Sciences ( GILD ), Alkermes ( ALKS ) and Vertex ( VRTX ).